Back
Alnylam Pharmaceuticals Stock Predictions
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
28
ALNY
Alnylam Pharmaceuticals
Last Price:
273.15
Seasonality Move:
5.61%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Alnylam Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 36.7% based on the past 20 years of stock performance.
- Alnylam Pharmaceuticals has risen higher in 14 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
-
Is Alnylam Pharmaceuticals Stock Undervalued?
The current Alnylam Pharmaceuticals [ALNY] share price is $274.46. The Score for ALNY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal. - ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Alnylam Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 36.7% based on the past 20 years of stock performance.
Alnylam Pharmaceuticals Stock Rating
Sell
28
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals overpriced?
- Alnylam Pharmaceuticals has risen higher in 14 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Alnylam Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alnylam.com
52-Week Data
52-Week High:
287.55
52-Week Low:
141.98
Prediction Charts
Market Cap:
35.24B
Price in USD:
274.46
Volume:
758.08K
Beta:
1.20
Technical Analysis
SMA50:
259.05
SMA100:
214.54
SMA200:
190.61
52-Wk Change:
48.36%
Stock Predictions
-
Is Alnylam Pharmaceuticals stock public?
Yes, Alnylam Pharmaceuticals is a publicly traded company. -
What is the Alnylam Pharmaceuticals stock quote today?
The Alnylam Pharmaceuticals stock price is 274.46 USD today. -
How to buy Alnylam Pharmaceuticals stock online?
You can buy Alnylam Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Aug-28 | 280.00 | 280.70 | 286.00 | 274.00 |
| Aug-29 | 279.41 | 287.01 | 287.55 | 279.41 |
| Aug-30 | 266.00 | 262.69 | 273.24 | 256.91 |
| Sep-3 | 260.44 | 253.73 | 263.10 | 252.76 |
| Sep-4 | 253.51 | 253.14 | 255.16 | 248.18 |
| Sep-5 | 251.86 | 251.36 | 255.24 | 249.95 |
| Sep-6 | 252.35 | 246.78 | 253.44 | 244.88 |
| Sep-9 | 246.65 | 252.98 | 255.48 | 246.65 |
| Sep-10 | 251.13 | 256.21 | 257.00 | 249.89 |
| Sep-11 | 256.75 | 261.86 | 263.65 | 256.11 |
| Sep-12 | 260.42 | 261.73 | 266.80 | 259.99 |
| Sep-13 | 261.00 | 265.27 | 265.52 | 259.01 |
| Sep-16 | 266.66 | 270.37 | 271.16 | 264.37 |
| Sep-17 | 271.21 | 274.46 | 274.57 | 270.24 |
Alnylam Pharmaceuticals Earnings
Alnylam Pharmaceuticals Earnings Report: Per Share Alnylam Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Alnylam Pharmaceuticals Forecast Revenue Growth
Alnylam Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.